Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts
Blood, 15 January 2005, Vol. 105, No. 2, pp. 847-854.
Prepublished online as a Blood First Edition Paper on July 1, 2004; DOI 10.1182/blood-2003-08-2942.


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
2003-08-2942v1
105/2/847    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Slichter, S. J
Right arrow Articles by Bolgiano, D.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Slichter, S. J
Right arrow Articles by Bolgiano, D.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

arrow to previous article Previous Article  |  Next Article next article arrow

Submitted August 27, 2003
Accepted May 29, 2004

Evaluation of different methods of leukoreduction of donor platelets to prevent alloimmune platelet refractoriness and induce tolerance in a canine transfusion model

Sherrill J Slichter*, Douglas Fish, V Kraig Abrams, Lakshmi K Gaur, Karen Nelson, and Doug Bolgiano

Research Division, Puget Sound Blood Center, Seattle, WA, USA
University of Washington School of Medicine, Seattle, WA, USA

* Corresponding author; email: sjslichter{at}psbc.org.

The effectivness of different methods of leukoreduction in preventing alloimmune platelet refractoriness was evaluated in a canine model. Platelets from a random donor dog were administered for 8 weeks or until platelet refractoriness. Acceptance rates were 14% for standard (STD) (unmodified) platelets (n=7), 14% for centifuge leukoreduced (CLR) platelets (n=21), and 31% for filter leukoreduced (F-LR) platelets (n=13), no significant differences. Surprisingly, combining F-LR and C-LR was highly effective (87% acceptance, n=15). Transfusing F-LR/C-LR red blood cells (n=4) or F-LR/C-LR plasma (n=4), along with F-LR/C-LR platelets did not compromise the effectiveness of F-LR/C-LR platelets (both 100% acceptance). The overall acceptance rate for F-LR/C-LR platelets was 91% (n=23) (p=<0.05 versus STD, C-LR, or F-LR platelets). F-LR/C-LR transfusions also induced tolerance to subsequent STD platelet transfusions from the same donor (82% acceptance, n=19) as well as to donor skin grafts without recipient immunosuppression (57% acceptance, n=7). To evaluate mechanisms of tolerance induction, F-LR/C-LR platelets were g-irradiated. Although the g-irradiated F-LR/C-LR platelets were still accepted (100% acceptance, n=6), tolerance to STD platelets was lost. These data suggest that some allostimulatory white cells are filter adherent while others escape filtration but can be removed by centrifugation and tolerance requires a residual functioning white cell.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?




 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
Sponsor: Genentech BioOncology and and Biogen Idec
Blood Online is supported in part by
Genentech BioOncology and Biogen Idec
  Copyright © 2004 by American Society of Hematology         Online ISSN: 1528-0020